Skip to main content
AVAH
NASDAQ Life Sciences

Aveanna Healthcare Refinances $1.3B Debt, Cuts Interest Margins by 50 Bps

Reported by Wiseek News
Sentiment info
Positive
Importance info
8
Price
$7.35
Mkt Cap
$1.598B
52W Low
$3.73
52W High
$10.32
Market data snapshot near publication time

Summary

Aveanna Healthcare completed a significant $1.318 billion term loan refinancing, which follows an 8-K filed earlier today detailing the same event. This move reduces the company's interest rate margins by 50 basis points, immediately lowering borrowing costs on a substantial portion of its debt. The refinancing also includes a new $250 million revolving credit facility, maintaining liquidity. This reduction in interest expense will positively impact the company's profitability and cash flow. An additional 25 basis point margin reduction is available if the company achieves a higher credit rating.

At the time of this announcement, AVAH was trading at $7.35 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $3.73 to $10.32. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

AVAH - Latest Insights

AVAH
May 28, 2026, 8:03 AM EDT
Source: Wiseek News
Importance Score:
8
AVAH
May 28, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
8
AVAH
May 14, 2026, 7:04 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
AVAH
May 14, 2026, 7:00 AM EDT
Filing Type: 10-Q
Importance Score:
8
AVAH
May 14, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
8
AVAH
Apr 17, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
7
AVAH
Mar 20, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
7
AVAH
Mar 19, 2026, 3:33 PM EDT
Filing Type: 10-K
Importance Score:
9
AVAH
Mar 19, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
8
AVAH
Mar 12, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
8